As part of the partnership, Summit will manufacture a multidose nasal spray presentation of AdCOVID, Altimmune’s intranasal COVID-19 vaccine candidate. AdCOVID is currently being evaluated in a phase 1 clinical trial of healthy adult volunteers between the ages of 18 and 55.
The University of Kentucky and Lexmark International are embarking on the next chapter in their longstanding partnership through a new agreement designed to accelerate innovation and spur economic growth.
While equestrian helmets protect riders, there is no test in place to evaluate a helmet’s crush resistance. UK students are working to develop a helmet testing method and collect data that will hopefully serve as the start of a crushing-safety standard for helmets.
The new facility will be named “The Core — Collaboration. Research. Entrepreneurship,” and is designed to be the first stop for companies looking to locate on the research campus.
UK's Office of Technology Commercialization (OTC), on behalf of UK Research Foundation (UKRF), was awarded a three-year $600,000 grant from the Economic Development Administration (EDA) Build to Scale Program, one of 52 projects funded from 36 states.
“This project will allow us to significantly reduce the complexity and cost of CO2 capture and biofixation from all sources, whether it is from utility companies, cement manufacturing, or chemical plants."
“This is a great opportunity to carry our efforts beyond Kentucky and the United States,” said Seth DeBolt, director of the James B. Beam Institute for Kentucky Spirits. “To partner with such an established institute will elevate the efforts we’ve already begun at the Beam Institute.”
The funding will further ongoing substance use disorder treatment research in collaboration with Sharon Walsh at the UK Center on Drug and Alcohol Research (CDAR) and Mei-Chuan Ko at the Wake Forest School of Medicine.
PDS0203 stands out among COVID-19 vaccines currently in development because it includes a vaccine technology pioneered by PDS Biotech called Versamune®, which stimulates important parts of the immune system to activate T cells.
“We all want to grow Kentucky’s tech sector and create the high-paying, knowledge-based jobs that follow. A big part of doing so is turning Kentucky’s own academic research and development capabilities into commercially viable products and startups.”
